Status:
COMPLETED
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma
Lead Sponsor:
Pfizer
Conditions:
Asthma
Diabetes Mellitus
Eligibility:
All Genders
18-77 years
Phase:
PHASE3
Brief Summary
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics with Asthma
Eligibility Criteria
Inclusion
- Diabetes Mellitus (Type 1 or Type 2) currently controlled with injected insulin
- Mild intermittent or mild to moderate persistent asthma
Exclusion
- Poorly controlled, unstable or steroid-dependent asthma, insulin pump therapy, smoking
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT00139659
Start Date
January 1 2003
End Date
October 1 2008
Last Update
June 2 2010
Active Locations (102)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Glendale, Arizona, United States, 85306
2
Pfizer Investigational Site
Peoria, Arizona, United States, 85381
3
Pfizer Investigational Site
Phoenix, Arizona, United States, 85004
4
Pfizer Investigational Site
Phoenix, Arizona, United States, 85006